Skip to main content
Erschienen in: Pituitary 2/2012

01.06.2012

Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas

verfasst von: L. G. Sobrinho, J. S. Duarte, I. Paiva, L. Gomes, V. Vicente, P. Aguiar

Erschienen in: Pituitary | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

It has been reported that women with prolactinoma were exposed, early in life, to an environment characterized by an absent or violent father. The present study was designed to evaluate whether paternal absence or violent paternal behavior were more prevalent in patients with pituitary adenomas (prolactinoma, acromegaly, non-secreting adenoma and Cushing’s disease) compared to a control population. We conducted an observational case–control multicenter study. We interviewed 395 patients with prolactinoma (296 females and 99 males), 130 with acromegaly (87 females and 43 males), 237 with non-secreting adenoma (144 females and 93 males) and 68 with Cushing’s disease (61 females and 7 males) and 365 patients from the same clinics with nodular thyroid disease or lymphocytic thyroiditis with euthyroidism as controls. Violent or absent fathers were significantly more prevalent in patients with prolactinoma or acromegaly than in controls (P = 0.001 and P = 0.002, respectively) but not in patients with non-secreting adenoma or corticotrophinoma. Absent fathers in prolactinoma and acromegaly versus controls: P = 0.001 and P = 0.119. Violent fathers in prolactinoma and acromegaly versus controls: P = 0.069 and P = 0.001. The prevalence of absent or violent fathers was also significantly higher in prolactinoma and acromegaly when compared to non-secreting adenoma (P = 0.039 and P = 0.033, respectively). Paternal deprivation before adolescence may be a risk factor for prolactinoma and acromegaly but not for non-secreting pituitary adenomas or Cushing’s disease.
Literatur
1.
Zurück zum Zitat Nunes MCP, Sobrinho LG, Calhaz-Jorge C, Santos MA, Mauricio JC, Sousa MFF (1980) Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea. Obstet Gynecol 55:591–595PubMed Nunes MCP, Sobrinho LG, Calhaz-Jorge C, Santos MA, Mauricio JC, Sousa MFF (1980) Psychosomatic factors in patients with hyperprolactinemia and/or galactorrhea. Obstet Gynecol 55:591–595PubMed
2.
Zurück zum Zitat Rojas LM, Sthory I, Canales ES, Zarate A (1981) Psychogenic factors in the syndrome of amenorrea-galactorrhea. Ginecologia y Obstetricia de Mexico 49:294–295 Rojas LM, Sthory I, Canales ES, Zarate A (1981) Psychogenic factors in the syndrome of amenorrea-galactorrhea. Ginecologia y Obstetricia de Mexico 49:294–295
3.
Zurück zum Zitat Jürgensen O, Barde B (1983) Psychodynamic findings in women with elevated serum prolactin. In: Dennerstein L, de Senarclens M (eds) The young woman. Psychosomatic aspects of obstetrics and gynecology. Excerpta Medica, I.C.S. 618, Amsterdam, p 120–148 Jürgensen O, Barde B (1983) Psychodynamic findings in women with elevated serum prolactin. In: Dennerstein L, de Senarclens M (eds) The young woman. Psychosomatic aspects of obstetrics and gynecology. Excerpta Medica, I.C.S. 618, Amsterdam, p 120–148
4.
Zurück zum Zitat Sobrinho LG, Nunes MCP, Calhaz-Jorge C, Afonso AM, Pereira MC, Santos MA (1984) Hyperprolactinemia in women with paternal deprivation during childhood. Obstet Gynecol 64:465–468PubMed Sobrinho LG, Nunes MCP, Calhaz-Jorge C, Afonso AM, Pereira MC, Santos MA (1984) Hyperprolactinemia in women with paternal deprivation during childhood. Obstet Gynecol 64:465–468PubMed
5.
Zurück zum Zitat Assies J, Vingerhoets AJJM, Poppelaars K (1992) Psychosocial aspects of hyperprolactinemia. Psychoneuroendocrinology 17:673–679PubMedCrossRef Assies J, Vingerhoets AJJM, Poppelaars K (1992) Psychosocial aspects of hyperprolactinemia. Psychoneuroendocrinology 17:673–679PubMedCrossRef
6.
Zurück zum Zitat Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6:35–39PubMedCrossRef Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6:35–39PubMedCrossRef
7.
Zurück zum Zitat Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC (2010) Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 67:113–123PubMedCrossRef Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC (2010) Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 67:113–123PubMedCrossRef
8.
Zurück zum Zitat Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606–612PubMedCrossRef Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM (1988) Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606–612PubMedCrossRef
9.
Zurück zum Zitat Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ (2002) Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 110:973–981PubMed Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ (2002) Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 110:973–981PubMed
10.
Zurück zum Zitat Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone–producing tumors: clinical, biochemical and morphological manifestations. Endocr Rev 9:357–373PubMedCrossRef Sano T, Asa SL, Kovacs K (1988) Growth hormone-releasing hormone–producing tumors: clinical, biochemical and morphological manifestations. Endocr Rev 9:357–373PubMedCrossRef
11.
Zurück zum Zitat Kovacs K, Stefaneanu L, Horvath E, Buchfelder M, Fahlbusch R, Althoff PH, Moore C (1996) Pituitary corticotroph adenoma in a woman with long-standing Addison’s disease: A histologic, immunocytochemical, electron microscopic and in situ hybridization study. Endocr Pathol 7:91–97PubMedCrossRef Kovacs K, Stefaneanu L, Horvath E, Buchfelder M, Fahlbusch R, Althoff PH, Moore C (1996) Pituitary corticotroph adenoma in a woman with long-standing Addison’s disease: A histologic, immunocytochemical, electron microscopic and in situ hybridization study. Endocr Pathol 7:91–97PubMedCrossRef
12.
Zurück zum Zitat Buurman H, Sager W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753–758PubMedCrossRef Buurman H, Sager W (2006) Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 154:753–758PubMedCrossRef
13.
Zurück zum Zitat Melmed S, Kleinberg D (2008) Anterior pituitary. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders, Philadelphia, pp 155–261 Melmed S, Kleinberg D (2008) Anterior pituitary. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Saunders, Philadelphia, pp 155–261
14.
Zurück zum Zitat Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney M (1997) Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277:1659–1662PubMedCrossRef Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney M (1997) Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277:1659–1662PubMedCrossRef
15.
Zurück zum Zitat McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348PubMedCrossRef McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12:342–348PubMedCrossRef
17.
Zurück zum Zitat Sonino N, Navarrini C, Ruini C, Fallo F, Boscaro M, Fava GA (2004) Life events in the pathogenesis of hyperprolactinemia. Eur J Endocrinol 151:61–65PubMedCrossRef Sonino N, Navarrini C, Ruini C, Fallo F, Boscaro M, Fava GA (2004) Life events in the pathogenesis of hyperprolactinemia. Eur J Endocrinol 151:61–65PubMedCrossRef
18.
Zurück zum Zitat Sonino N, Fava GA, Grandi S, Mantero F, Boscaro M (1988) Stressful life events in the pathogenesis of Cushing’s syndrome. Clin Endocrinol 29:617–623CrossRef Sonino N, Fava GA, Grandi S, Mantero F, Boscaro M (1988) Stressful life events in the pathogenesis of Cushing’s syndrome. Clin Endocrinol 29:617–623CrossRef
19.
Zurück zum Zitat Sobrinho LG, Simoes M, Barbosa L, Raposo JF, Pratas S, Fernandes PL, Santos MA (2003) Cortisol, prolactin and growth hormone responses to emotions elicited during an hypnoidal state. Psychoneuroendocrinology 28:1–17PubMedCrossRef Sobrinho LG, Simoes M, Barbosa L, Raposo JF, Pratas S, Fernandes PL, Santos MA (2003) Cortisol, prolactin and growth hormone responses to emotions elicited during an hypnoidal state. Psychoneuroendocrinology 28:1–17PubMedCrossRef
20.
Zurück zum Zitat Sobrinho LG (1991) Neuropsychiatry of prolactin: causes and effects. Baillière’s Clin Endocrinol Metab 5:119–141CrossRef Sobrinho LG (1991) Neuropsychiatry of prolactin: causes and effects. Baillière’s Clin Endocrinol Metab 5:119–141CrossRef
21.
Zurück zum Zitat Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-López P, Gálvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naïve acromegaly. J Clin Endocrinol Metab 95:4367–4379PubMedCrossRef Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-López P, Gálvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naïve acromegaly. J Clin Endocrinol Metab 95:4367–4379PubMedCrossRef
22.
Zurück zum Zitat Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross sectional study in 81 acromegalic patients. Clin Endocrinol 71:691–701CrossRef Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross sectional study in 81 acromegalic patients. Clin Endocrinol 71:691–701CrossRef
23.
Zurück zum Zitat Tiemensma J, Nienke R, Biermasz NR, van der Mast RC, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning in patients after long term cure of acromegaly. J Clin Endocrinol Metab 95: E392-E402. doi:10.1210/jc.2010-1253 Tiemensma J, Nienke R, Biermasz NR, van der Mast RC, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning in patients after long term cure of acromegaly. J Clin Endocrinol Metab 95: E392-E402. doi:10.​1210/​jc.​2010-1253
Metadaten
Titel
Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas
verfasst von
L. G. Sobrinho
J. S. Duarte
I. Paiva
L. Gomes
V. Vicente
P. Aguiar
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 2/2012
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0324-1

Weitere Artikel der Ausgabe 2/2012

Pituitary 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.